Please ensure Javascript is enabled for purposes of website accessibility

securities fraud

Nov 19, 2025

Criminal – Securities fraud

Where a jury found a defendant guilty of securities fraud, his conviction and sentence should be affirmed because (1) any error in admitting evidence summarizing his bank account activity was harmless, (2) sufficient evidence supported the jury’s verdict, (3) the lower court’s loss calculation was fully supported by reliable evidence, and (4) the defendant has failed to show that the restituti[...]

Unraveling Ponzi schemes using advanced data analytics
Apr 1, 2022

Attorneys see rocky road for SEC climate initiative

While questions abound as to their final form, attorneys are confident that the Securities and Exchange Commission will adopt some version of ambitious climate disclosure rules proposed last month. And […]

Jan 29, 2016

Real estate co. owner convicted of securities fraud based on cocktail napkin

The U.S. Attorney’s Office has secured a securities fraud conviction by building its case on the defendant’s purchase of stock based on a cocktail napkin tip from a friend. Robert H. Bray […]

Oct 11, 2011

Securities – Fraud – Scienter – GAAP

Where a plaintiff has brought a class action for securities fraud against the defendant healthcare corporation and two of its executives, the complaint should be dismissed because, although the defendants did not adhere to generally accepted accounting principles, there was insufficient evidence of fraudulent intent or recklessness to raise a strong inference of scienter.

Aug 17, 2011

Securities – Fraud – Scienter

Where a securities class action was brought alleging that senior management of a defendant corporation, a publicly traded manufacturer of medical devices in which plaintiff invested, withheld material information and made misleading statements, the defendant was correctly awarded summary judgment based on the plaintiffs' failure to prove scienter.

Aug 5, 2011

Securities – Fraud – ERISA

Where defendants have moved to dismiss claims brought pursuant to the Securities Exchange Act of 1934, the Securities Act of 1933 and the Employee Retirement Income Security Act (ERISA), the plaintiffs' allegations of misrepresentation concerning the defendants' foreign exchange trades are sufficient to withstand the dismissal motions.

Aug 5, 2011

Securities – Fraud – Market timing – Limitations

Where the Securities and Exchange Commission has brought a disgorgement action against a defendant charged with securities fraud, the defendant has not shown that the charges in the SEC's complaint are time-barred and thus a motion he filed for summary judgment must be denied.

Jul 20, 2011

Securities – Fraud – Materiality – Scienter

Where a defendant corporation and its codefendant chief executive officer have moved to dismiss a putative federal securities class action, the motion should be allowed without prejudice, as the CEO's statements claimed by the defendants to be misleading do not satisfy the elements of material misrepresentation and scienter.

May 12, 2011

Down the rabbit hole with the U.S. Supreme Court

On March 22, 2011, the U.S. Supreme Court rendered a unanimous decision in the case of Matrixx Initiatives Inc. v. Siracusano, defining “materiality" in securities fraud claims.

Jan 21, 2011

Securities – Scienter

Where a securities fraud complaint was dismissed, this was proper in light of the complaint's failure to meet the "strong inference" of scienter standard set forth in the Private Securities Litigation Reform Act of 1995.

Verdicts & Settlements

See All Verdicts & Settlements

Opinion Digests

See All Digests